Aims: Endoscopic ultrasound guided Fine-needle aspiration biopsy (EUS-FNA) has proven to be an effective diagnostic modality for the detection and staging of pancreatic malignancies. In recent years EUS-FNA has also been used to diagnose lesions of non-pancreatic sites such as structures in close proximity to the gut wall within the mediastinum, abdomen, pelvis and retro-peritoneum. In this study we evaluated our experience with EUS-FNA of the non-pancreatic sites. Methods: The study cohort included 234 patients; 144 males and 90 females (mean age 64.3 yrs) who underwent EUS-FNA of 246 lesions in non-pancreatic sites. These included 122 peri-pancreatic and celiac lymph nodes, 9 peripancreatic masses, mediastinum 12, gastric 25, liver 27, esophagus 17, duodenum/colon/rectum 15, retro-peritoneum 8, lung 7, and 4 miscellaneous cases. Results: The cytology diagnoses were classified as non-neoplastic/reactive 82 (33%), atypical/suspicious for malignancy 25 (10%), malignant 86 (35%) and non-diagnostic 53 (22%) cases. Surgical pathology follow-up was available in 75(31%) cases. Excluding the non-diagnostic cases there were 7 false negative and 3 false positive cases. The sensitivity, specificity and positive predictive value of EUS-FNA in the diagnosis of lesions of non-pancreatic sites was 92%, 98% and 97% respectively. Conclusions: EUS-FNA can be effectively used as a diagnostic modality in the diagnosis of lesions from non-pancreatic sites.
- Fine needle biopsy
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.